{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:23:18Z","timestamp":1761582198888,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovative Medicines Initiative 2","award":["116030"],"award-info":[{"award-number":["116030"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Programme","award":["116030"],"award-info":[{"award-number":["116030"]}]},{"DOI":"10.13039\/100013322","name":"European Federation of  Pharmaceutical Industries and Associations","doi-asserted-by":"crossref","award":["116030"],"award-info":[{"award-number":["116030"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002428","name":"Austrian  Science Fund\/FWF","doi-asserted-by":"crossref","award":["W1232"],"award-info":[{"award-number":["W1232"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EMBL core funding"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104104\/A\/14\/Z","218244\/Z\/19\/Z"],"award-info":[{"award-number":["104104\/A\/14\/Z","218244\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Member States of the European Molecular Biology Laboratory"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As an alternative to one drug-one target approaches, systems biology methods can provide a deeper insight into the holistic effects of drugs. Network-based approaches are tools of systems biology, that can represent valuable methods for visualizing and analysing drug-protein and protein\u2013protein interactions. In this study, a KNIME workflow is presented which connects drugs to causal target proteins and target proteins to their causal protein interactors. With the collected data, networks can be constructed for visualizing and interpreting the connections. The last part of the workflow provides a topological enrichment test for identifying relevant pathways and processes connected to the submitted data. The workflow is based on openly available databases and their web services. As a case study, compounds of DILIRank were analysed. DILIRank is the benchmark dataset for Drug-Induced Liver Injury by the FDA, where compounds are categorized by their likeliness of causing DILI. The study includes the drugs that are most likely to cause DILI (\u201cmostDILI\u201d) and the ones that are not likely to cause DILI (\u201cnoDILI\u201d). After selecting the compounds of interest, down- and upregulated proteins connected to the mostDILI group were identified; furthermore, a liver-specific subset of those was created. The downregulated sub-list had considerably more entries, therefore, network and causal interactome were constructed and topological pathway enrichment analysis was performed with this list. The workflow identified proteins such as Prostaglandin G7H synthase 1 and UDP-glucuronosyltransferase 1A9 as key participants in the potential toxic events disclosing the possible mode of action. The topological network analysis resulted in pathways such as recycling of bile acids and salts and glucuronidation, indicating their involvement in DILI. The KNIME pipeline was built to support target and network-based approaches to analyse any sets of drug data and identify their target proteins, mode of actions and processes they are involved in. The fragments of the pipeline can be used separately or can be combined as required.<\/jats:p>","DOI":"10.1186\/s13321-022-00615-6","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T02:04:33Z","timestamp":1655085873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["KNIME workflow for retrieving causal drug and protein interactions, building networks, and performing topological enrichment analysis demonstrated by a DILI case study"],"prefix":"10.1186","volume":"14","author":[{"given":"Barbara","family":"F\u00fczi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahuman S.","family":"Malik-Sheriff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma J.","family":"Manners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Hermjakob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-6883","authenticated-orcid":false,"given":"Gerhard F.","family":"Ecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"615_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","volume":"18","author":"JL Medina-Franco","year":"2013","unstructured":"Medina-Franco JL, Giulianotti MA, Welmaker GS, Houghten RA (2013) Shifting from the single- to the multitarget paradigm in drug discovery. Drug Discov Today 18:495\u2013501. https:\/\/doi.org\/10.1016\/j.drudis.2013.01.008","journal-title":"Drug Discov Today"},{"key":"615_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","volume":"26","author":"P Csermely","year":"2005","unstructured":"Csermely P, \u00c1goston V, Pongor S (2005) The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26:178\u2013182. https:\/\/doi.org\/10.1016\/j.tips.2005.02.007","journal-title":"Trends Pharmacol Sci"},{"key":"615_CR3","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.12.74.10.1586\/ecp.12.74","author":"AS Reddy","year":"2013","unstructured":"Reddy AS, Zhang S (2013) Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol. https:\/\/doi.org\/10.1586\/ecp.12.74.10.1586\/ecp.12.74","journal-title":"Expert Rev Clin Pharmacol"},{"key":"615_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1021\/acs.chemrestox.7b00003","volume":"30","author":"T Hartung","year":"2017","unstructured":"Hartung T, FitzGerald RE, Jennings P et al (2017) Systems toxicology: real world applications and opportunities. Chem Res Toxicol 30:870\u2013882. https:\/\/doi.org\/10.1021\/acs.chemrestox.7b00003","journal-title":"Chem Res Toxicol"},{"key":"615_CR5","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1002\/pmic.200700131","volume":"7","author":"T Bergg\u00e5rd","year":"2007","unstructured":"Bergg\u00e5rd T, Linse S, James P (2007) Methods for the detection and analysis of protein\u2013protein interactions. Proteomics 7:2833\u20132842. https:\/\/doi.org\/10.1002\/pmic.200700131","journal-title":"Proteomics"},{"key":"615_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Y\u0131ld\u0131r\u0131m","year":"2007","unstructured":"Y\u0131ld\u0131r\u0131m MA, Goh K-I, Cusick ME et al (2007) Drug\u2014target network. Nat Biotechnol 25:1119\u20131126. https:\/\/doi.org\/10.1038\/nbt1338","journal-title":"Nat Biotechnol"},{"key":"615_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-1-4939-8618-7_16","volume":"1819","author":"C Hardt","year":"2018","unstructured":"Hardt C, Bauer C, Schuchhardt J, Herwig R (2018) Computational network analysis for drug toxicity prediction. Methods Mol Biol Clifton NJ 1819:335\u2013355. https:\/\/doi.org\/10.1007\/978-1-4939-8618-7_16","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"615_CR8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41467-021-21056-z","volume":"12","author":"A Belyaeva","year":"2021","unstructured":"Belyaeva A, Cammarata L, Radhakrishnan A et al (2021) Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing. Nat Commun 12:1024. https:\/\/doi.org\/10.1038\/s41467-021-21056-z","journal-title":"Nat Commun"},{"key":"615_CR9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12859-019-3146-1","volume":"20","author":"J Ma","year":"2019","unstructured":"Ma J, Shojaie A, Michailidis G (2019) A comparative study of topology-based pathway enrichment analysis methods. BMC Bioinformatics 20:546. https:\/\/doi.org\/10.1186\/s12859-019-3146-1","journal-title":"BMC Bioinformatics"},{"key":"615_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/bib\/bbaa377","volume":"22","author":"G Agapito","year":"2021","unstructured":"Agapito G, Pastrello C, Jurisica I (2021) Comprehensive pathway enrichment analysis workflows: COVID-19 case study. Brief Bioinform 22:676\u2013689. https:\/\/doi.org\/10.1093\/bib\/bbaa377","journal-title":"Brief Bioinform"},{"key":"615_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1145\/1656274.1656280","volume":"11","author":"MR Berthold","year":"2009","unstructured":"Berthold MR, Cebron N, Dill F et al (2009) KNIME\u2014the Konstanz information miner: version 2.0 and beyond. ACM SIGKDD Explor Newsl 11:26\u201331. https:\/\/doi.org\/10.1145\/1656274.1656280","journal-title":"ACM SIGKDD Explor Newsl"},{"key":"615_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","volume":"21","author":"M Chen","year":"2016","unstructured":"Chen M, Suzuki A, Thakkar S et al (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 21:648\u2013653. https:\/\/doi.org\/10.1016\/j.drudis.2016.02.015","journal-title":"Drug Discov Today"},{"key":"615_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.793332","author":"Y Shi","year":"2022","unstructured":"Shi Y, Hua Y, Wang B et al (2022) In silico prediction and insights into the structural basis of drug induced nephrotoxicity. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.793332","journal-title":"Front Pharmacol"},{"key":"615_CR14","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3389\/fphar.2021.708296","volume":"12","author":"B F\u00fczi","year":"2021","unstructured":"F\u00fczi B, Gurinova J, Hermjakob H et al (2021) Path4Drug: data science workflow for identification of tissue-specific biological pathways modulated by toxic drugs. Front Pharmacol 12:2824. https:\/\/doi.org\/10.3389\/fphar.2021.708296","journal-title":"Front Pharmacol"},{"key":"615_CR15","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP et al (2019) ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 47:D930\u2013D940. https:\/\/doi.org\/10.1093\/nar\/gky1075","journal-title":"Nucleic Acids Res"},{"key":"615_CR16","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"key":"615_CR17","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkx1121","volume":"46","author":"SD Harding","year":"2018","unstructured":"Harding SD, Sharman JL, Faccenda E et al (2018) The IUPHAR\/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. Nucleic Acids Res 46:D1091\u2013D1106. https:\/\/doi.org\/10.1093\/nar\/gkx1121","journal-title":"Nucleic Acids Res"},{"key":"615_CR18","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento AP, Gaulton A, Hersey A et al (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res 42:D1083\u2013D1090. https:\/\/doi.org\/10.1093\/nar\/gkt1031","journal-title":"Nucleic Acids Res"},{"key":"615_CR19","doi-asserted-by":"publisher","first-page":"D1153","DOI":"10.1093\/nar\/gkz974","volume":"48","author":"P Samaras","year":"2020","unstructured":"Samaras P, Schmidt T, Frejno M et al (2020) ProteomicsDB: a multi-omics and multi-organism resource for life science research. Nucleic Acids Res 48:D1153\u2013D1163. https:\/\/doi.org\/10.1093\/nar\/gkz974","journal-title":"Nucleic Acids Res"},{"key":"615_CR20","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC et al (2021) The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49:D605\u2013D612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074","journal-title":"Nucleic Acids Res"},{"key":"615_CR21","doi-asserted-by":"publisher","first-page":"D504","DOI":"10.1093\/nar\/gkz949","volume":"48","author":"L Licata","year":"2020","unstructured":"Licata L, Lo Surdo P, Iannuccelli M et al (2020) SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update. Nucleic Acids Res 48:D504\u2013D510. https:\/\/doi.org\/10.1093\/nar\/gkz949","journal-title":"Nucleic Acids Res"},{"key":"615_CR22","doi-asserted-by":"publisher","first-page":"i451","DOI":"10.1093\/bioinformatics\/bts389","volume":"28","author":"E Glaab","year":"2012","unstructured":"Glaab E, Baudot A, Krasnogor N et al (2012) EnrichNet: network-based gene set enrichment analysis. Bioinforma Oxf Engl 28:i451\u2013i457. https:\/\/doi.org\/10.1093\/bioinformatics\/bts389","journal-title":"Bioinforma Oxf Engl"},{"key":"615_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1028","author":"M Gillespie","year":"2021","unstructured":"Gillespie M, Jassal B, Stephan R et al (2021) The reactome pathway knowledgebase 2022. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkab1028","journal-title":"Nucleic Acids Res"},{"key":"615_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/bib\/bbx091","volume":"20","author":"Q Yang","year":"2019","unstructured":"Yang Q, Wang S, Dai E et al (2019) Pathway enrichment analysis approach based on topological structure and updated annotation of pathway. Brief Bioinform 20:168\u2013177. https:\/\/doi.org\/10.1093\/bib\/bbx091","journal-title":"Brief Bioinform"},{"issue":"7","key":"615_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/bib\/bbx091","volume":"25","author":"I \u0106avar","year":"2010","unstructured":"\u0106avar I, Kelava T, Vukojevi\u0107 K, et al (2010) The role of prostaglandin E2 in acute acetaminophen hepatotoxicity in mice. Histol Histopathol 25(7):819-30. https:\/\/doi.org\/10.14670\/HH-25.819","journal-title":"Histol Histopathol"},{"key":"615_CR26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1124\/mol.62.3.608","volume":"62","author":"J-F Gagn\u00e9","year":"2002","unstructured":"Gagn\u00e9 J-F, Montminy V, Belanger P et al (2002) Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 62:608\u2013617. https:\/\/doi.org\/10.1124\/mol.62.3.608","journal-title":"Mol Pharmacol"},{"key":"615_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0163-7258(00)00109-1","volume":"89","author":"K Grancharov","year":"2001","unstructured":"Grancharov K, Naydenova Z, Lozeva S, Golovinsky E (2001) Natural and synthetic inhibitors of UDP-glucuronosyltransferase. Pharmacol Ther 89:171\u2013186. https:\/\/doi.org\/10.1016\/S0163-7258(00)00109-1","journal-title":"Pharmacol Ther"},{"key":"615_CR28","doi-asserted-by":"publisher","unstructured":"Kullak-Ublick GA, Ismair MG, Stieger B et al (2001) Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120(2):525-33. https:\/\/doi.org\/10.1053\/gast.2001.21176","DOI":"10.1053\/gast.2001.21176"},{"key":"615_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"A-L Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si A-L, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56\u201368. https:\/\/doi.org\/10.1038\/nrg2918","journal-title":"Nat Rev Genet"},{"key":"615_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1124\/dmd.113.054205","volume":"42","author":"AD Rodrigues","year":"2014","unstructured":"Rodrigues AD, Lai Y, Cvijic ME et al (2014) Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump. Drug Metab Dispos 42:566\u2013574. https:\/\/doi.org\/10.1124\/dmd.113.054205","journal-title":"Drug Metab Dispos"},{"key":"615_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.toxlet.2017.05.024","volume":"277","author":"SM Iqbal","year":"2017","unstructured":"Iqbal SM, Lemmens-Gruber R (2017) Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity. Toxicol Lett 277:64\u201368. https:\/\/doi.org\/10.1016\/j.toxlet.2017.05.024","journal-title":"Toxicol Lett"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00615-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-022-00615-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-022-00615-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T02:04:55Z","timestamp":1655085895000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-022-00615-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["615"],"URL":"https:\/\/doi.org\/10.1186\/s13321-022-00615-6","relation":{},"ISSN":["1758-2946"],"issn-type":[{"type":"electronic","value":"1758-2946"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}